selected publications
- Actomyosin-Mediated Cellular Tension Drives Increased Tissue Stiffness and β-Catenin Activation to Induce Epidermal Hyperplasia and Tumor Growth. 2024 GET IT
- Immunogenicity of COVID-19 mRNA vaccines in patients with acute myeloid leukemia and myelodysplastic syndrome. Leukemia & lymphoma. 2022 Academic Article GET IT
-
Adoptive immunotherapy with CB following chemotherapy for patients with refractory myeloid malignancy: chimerism and response.
Blood advances.
2020
Academic Article
GET IT
Times cited: 4 - Phase II study of the clinical efficacy and safety of tosedostat in patients with myelodysplastic syndromes (MDS) after failure of hypomethylating agent-based therapy. Leukemia & lymphoma. 2020 Article GET IT
-
Adoptive Immunotherapy with Cord Blood for the Treatment of Refractory Acute Myelogenous Leukemia: Feasibility, Safety, and Preliminary Outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.
2018
Academic Article
GET IT
Times cited: 2 -
Somatic mutations precede acute myeloid leukemia years before diagnosis.
Nature medicine.
2018
Academic Article
GET IT
Times cited: 387 -
Patients treated with oxaliplatin are at risk for thrombocytopenia caused by multiple drug-dependent antibodies.
Blood.
2018
Article
GET IT
Times cited: 14 -
Prevalence, management, and clinical consequences of QT interval prolongation during treatment with arsenic trioxide.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
2014
Academic Article
GET IT
Times cited: 46 -
Arsenic trioxide and low-dose cytarabine for patients with intermediate-2 and high-risk myelodysplastic syndrome.
Leukemia research.
2010
Academic Article
GET IT
Times cited: 8 -
Arsenic trioxide and low-dose cytarabine in older patients with untreated acute myeloid leukemia, excluding acute promyelocytic leukemia.
Cancer.
2008
Academic Article
GET IT
Times cited: 42